IRCT20170606034348N6
Recruiting
Phase 3
Comparing changes of biochemical factors in serum of patients with bipolar disorder who received Aripiprazol versus Perfenazin
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Bipolar disorder.
- Sponsor
- Babol University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •No Psychotic symptom
- •Bipolar disorder diagnosis based on DSM\-4\-TR
- •Filling in the personal satisfaction form
- •Ages between 18\-50 years
Exclusion Criteria
- •Hypertension
- •High blood lipids
- •Antihypertensive and antihypertensive drugs
- •Diabetes mellitus type\-II
- •Physical disorders
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 4
Comparing serum biochemistry change after loading Sterofundin, Normal saline, and Acetar in suspected septic shock patients.Severe sepsis/septic shock patients who required fluid resuscitation since Emergency Medicine Department of Faculty of Medicine Vajira Hospital.Fluid resuscitino,normal saline,acetar,sterofundin,serum chloride,biochemistryTCTR20160618001Faculty of Medicine Vajira Hospital30
Not yet recruiting
Phase 3
Comparison of serum cortisol level of intubating devices(Macintosh Laryngoscope and besdata video intubating stylet)Health Condition 1: O- Medical and SurgicalHealth Condition 2: K928- Other specified diseases of the digestive systemHealth Condition 3: K928- Other specified diseases of the digestive systemCTRI/2021/07/035051Department of Anaesthesiology and critical careJNMCHAMUAligarh
Not yet recruiting
Not Applicable
To correlate the features of Taila Bindu Pariksha with Serum Urea and Creatinine in Renal Failure patients before and after dialysis.Health Condition 1: N19- Unspecified kidney failureCTRI/2023/02/049525Head of Department of Vikriti Vigyan
Completed
Not Applicable
Retrospective study of COVID-19CTRI/2021/12/038934Yenepoya Medical College52
Completed
Phase 1
Checking effect of an ayurvedic treatment on urine and serum metabolites in hyperlipidemic patientsHealth Condition 1: null- hyperlipidemia, triglyceride 300 mg/dL and cholesterol in the range of 130- 230 mg/dCTRI/2016/08/007187Central Council for Research in Ayurvedic Sciences50